The launch of the the medication vial marks a notable breakthrough in the approach to weight control . This groundbreaking drug combines two mechanisms – stimulation of the GLP-1 receptor and inhibition of the DPP-4 enzyme – offering a distinctive strategy for addressing weight concerns. Early clinical data suggest promising results in facilita